Axt stock has moved sharply over the past year, delivering a very large gain that now sits against valuation checks which lean toward the shares looking expensive on current metrics.

• Over the past 1 year, AXT has returned about 23x, which puts a lot of recent optimism into the current share price.
• New multi year indium phosphide wafer supply deals with Coherent and Nanjing Casela can support expectations for higher revenue and capacity utilisation. At the same time, execution risk around expanding production and meeting long term commitments may weigh on how much investors are willing to pay for that growth.
• With a low value score of 2 out of 6, AXT does not screen as a clear bargain on the broader set of valuation checks.

The issue now is whether AXT's current price already reflects most of the good news in these recent contracts or still leaves room for further upside.

Is AXT Getting Expensive on Sales?

P/S is a useful way to look at AXT because the company is more revenue focused at this stage than earnings focused, and its P/E is currently affected by losses.

AXT is trading on a P/S of about 40.0x, which is well above the Semiconductor industry average of 7.5x and the peer average of 3.9x. The P/S multiple implied by broader factors such as growth assumptions, profitability profile, size and risk is around 18.2x, which is less than half of the level at which the stock is currently priced.

Because AXT recently signed sizable indium phosphide wafer deals with Coherent and Nanjing Casela, sentiment has moved quickly; however, the valuation now reflects a large premium to both sector norms and this fair multiple estimate.

On the P/S metric, AXT stock appears overvalued relative to what the implied multiple suggests.

The AXT Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for AXT aim to turn the valuation puzzle above into concrete scenarios by spelling out which paths for AXT's revenue growth, margins and earnings would need to play out for the stock to be worth materially more or less than its current price, and they sit on Simply Wall St's Community page. Where a single ratio or model produces one headline figure, these narratives lay out the future that figure relies on, so you can monitor whether it is still on track.

One of the top community narratives on AXT: 52% undervalued

"If the planned IPO of AXT's Tongmei subsidiary on the STAR Market in Shanghai materializes, this could unlock significant hidden value, catalyze reinvestment in capacity expansion, and serve as an immediate and dramatic catalyst for AXT's balance sheet strength and valuation…"

Do you think there's more to the story for AXT? Head over to our Community to see what others are saying!

The Bottom Line

For AXT, the market-multiple view points to an overvalued stock, with the current P/S sitting well above both sector norms and the tailored multiple implied by its risk and business profile. The low value score reinforces that broader checks are not especially supportive, even with the recent enthusiasm around new contracts. From here, the key question is whether AXT can sustain revenue growth and execution on its long term wafer agreements strongly enough to justify the current premium, or whether the multiple settles closer to peers if expectations cool.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.